Rinostop Nazal Spray. 0.05% 15ml vial with an activator and zasch.kolpachkom

$2.20

Rinostop Nazal Spray. 0.05% 15ml vial with an activator and zasch.kolpachkom

Quantity:

SKU: 206836326 Categories: , , Tags: ,

Description

Composition
Active substance:
1 mL contains: xylometazoline hydrochloride – 0.50 mg or 1.00 mg ;.
Excipients:
Disodium edetate (Trilon B) – 0.50 mg Sodium chloride – 9.00 mg Benzalkonium chloride – 0.15 mg Potassium dihydrogen phosphate – 3.63 mg sodium phosphate dodecahydrate – 7.13 mg Purified water – up to 1 ml.
Description:
Clear, colorless or slightly colored liquid.
Product form:
Nasal Spray 0.05% and 0.1%.
10, 15, 20 or 30 mL in plastic vials.
Each vial together with an activator in complete protective cap and instructions for use placed in a pile of cardboard.
Contraindications
Hypersensitivity to xylometazoline and other ingredients, hypertension, tachycardia, expressed atherosclerosis, glaucoma, atrophic rhinitis, surgical interventions in the meninges (history), conditions after transsphenoidal hypophysectomy, children (under 2 years – to 0.05% spray , aged 6 to 0.1% spray), pregnancy.
Do not use in the therapy of monoamine oxidase inhibitors and tricyclics (including a period of 14 days after their withdrawal).
Carefully
Diabetes mellitus, hyperthyroidism, pheochromocytoma, cardiovascular disease (including coronary heart disease), prostatic hyperplasia, lactation. Patients with hypersensitivity to adrenoceptor agonists, accompanied by symptoms of insomnia and dizziness.
Dosage
0.5 mg / ml
Indications
Applied with acute respiratory diseases with symptoms of rhinitis (common cold), acute allergic rhinitis, sinusitis, otitis media with (in combination therapy to reduce the swelling of the mucosa of the nasopharynx).
Preparing the patient for diagnostic procedures in the nasal passages.
Interaction with other drugs
Perhaps increased systemic action while applying monoamine oxidase inhibitors, and tricyclic antidepressants.
Overdose
In overdose or accidentally taking the drug inside may develop following symptoms: nausea, vomiting, cyanosis, fever, tachycardia, arrhythmia, increased blood pressure, dizziness, mental disorders, depression of the central nervous system (drowsiness, reduction of body temperature, bradycardia, decrease in blood pressure, breathing and coma stop).
Treatment: symptomatic: Accidental ingestion – gastric lavage, activated charcoal.
pharmachologic effect
Pharmacological group:
Decongestant agent – alpha-agonists.
Pharmacological properties:
Xylometazoline refers to a group of local vasoconstrictive agents (decongestants) with alpha-Adrenomimeticalkie activity causes vasoconstriction of nasal mucosa, thereby eliminating, edema and hyperemia of the nasal mucosa, nasal restores patency, easier nasal breathing.
Effect of the drug occurs within a few minutes after its application and continues until 10 hours.
Pharmacokinetics:
When applied topically, the drug is practically not absorbed, however, its concentration in the blood plasma is very low (modern analytical methods not determined).
Pregnancy and breast-feeding
During pregnancy, the use of the drug is contraindicated.
During lactation the drug should be used only on prescription, after a careful assessment of risks and benefits for mother and child. It is not allowed to exceed the recommended dosage.
Conditions of supply of pharmacies
Without recipe.
side effects
With frequent and / or prolonged use – irritation and / or dryness of the nasal mucosa, burning and paresthesia nasal mucous membrane, sneezing, hypersecretion of mucous membrane of the nasal cavity; swelling of the nasal mucosa, vomiting, headache, palpitations, hypertension, tachycardia, arrhythmia, insomnia, visual disturbances, depression (with prolonged use of high doses).
Benzalkonium chloride, part of the drug may irritate the nasal mucosa.
special instructions
They should not be used for a long time (more than 7 days), for example, in chronic rhinitis.
Avoid the drug in the eye (the drug affects the vision).
Prolonged use (more than one week) possible return of symptoms of nasal congestion.
The effect on the ability to operate a vehicle or equipment:
In the case of systemic side effects (headache, palpitations, high blood pressure, blurred vision) should refrain from driving and other activities potentially hazardous activities that require high concentration and psychomotor speed reactions.
Storage conditions
At a temperature of 2 to 25 C.
Keep out of the reach of children.
Dosing and Administration
Intranasally.
Spraying is carried out after removing the protective cap from the dispenser. Nebulizer and administered to the nose by pressing on its base, sprayed for 1 second.
For adults and children over the age of 6 years (0.1% spray): one injection of the spray gun in each nostril, usually enough 3-4 injections per day; should not be used more than 3 times a day.
Children aged 2 to 6 years old (0.05% spray) injection of one sprayer into each nasal passage of 1 or 2 times per day; should not be used more than 3 times a day.
Do not use the drug without interruption for more than 3-5 days.
During dosing spray bottle should be kept up !.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

OTISIFARM

There are no reviews yet.

Add your review